Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models
- Author
- LUCA GRAVINA, Giovanni1 2 ; MARAMPON, Francesco1 2 ; GIUSTI, Ilaria3 ; CAROSA, Eleonora4 ; DI SANTE, Stefania4 ; RICEVUTO, Enrico5 ; DOLO, Vincenza3 ; TOMBOLINI, Vincenzo6 ; JANNINI, Emmanuele A4 ; FESTUCCIA, Claudio2
[1] Department of Experimental Medicine, Division of Radiotherapy, Italy
[2] Department of Experimental Medicine, Laboratory of Radiobiology, Italy
[3] Department of Health Sciences and, University of L'Aquila, 67100 L'Aquila, Italy
[4] Department of Experimental Medicine, Course of Endocrinology and Medical Sexology and, University of L'Aquila, 67100 L'Aquila, Italy
[5] Department of Experimental Medicine, Division of Clinical Oncology, University of L'Aquila, 67100 L'Aquila, Italy
[6] Department of Radiological Sciences, University of Rome 'La Sapienza' Spencer-Lorillard Foundation, 00100 Rome, Italy - Source
International journal of oncology. 2012, Vol 40, Num 3, pp 711-720, 10 p ; ref : 37 ref
- ISSN
- 1019-6439
- Scientific domain
- Medical oncology
- Publisher
- Editorial Academy of the International Journal of Oncology, Athens
- Publication country
- Greece
- Document type
- Article
- Language
- English
- Author keyword
- belinostat epigenetic histone deacetylation prostate cancer
- Keyword (fr)
- Androgène Anticancéreux Bélinostat Cancer de la prostate Cancérologie Désacétylation Epigénétique Histone Hormonodépendance Hormonoindépendance Modèle Cancer Hormone stéroïde sexuelle Inhibiteur histone deacetylase Pathologie de l'appareil génital mâle Pathologie de l'appareil urinaire Pathologie de la prostate Tumeur maligne
- Keyword (en)
- Androgen Antineoplastic agent Belinostat Prostate cancer Cancerology Deacetylation Epigenetics Histone Hormonodependence Hormonoindependence Models Cancer Sex steroid hormone Histone deacetylase inhibitor Male genital diseases Urinary system disease Prostate disease Malignant tumor
- Keyword (es)
- Andrógeno Anticanceroso Belinostat Cáncer de la próstata Cancerología Desacetilación Epigenética Histona Hormonodependencia Hormonoindependencia Modelo Cáncer Hormona esteroide sexual Inhibidor histone deacetylase Aparato genital macho patología Aparato urinario patología Prostata patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B14 Nephrology. Urinary tract diseases / 002B14D Tumors of the urinary system / 002B14D02 Urinary tract. Prostate gland
- Discipline
- Nephrology. Urinary tract diseases Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 25571322
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models\";s:9:\"\u0000*\u0000jtitle\";s:33:\"International journal of oncology\";s:9:\"\u0000*\u0000stitle\";s:13:\"Int. j. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"711\";s:8:\"\u0000*\u0000epage\";s:3:\"720\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1019-6439\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"LUCA GRAVINA\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Giovanni\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:19:\"MARAMPON, Francesco\";i:1;s:14:\"GIUSTI, Ilaria\";i:2;s:16:\"CAROSA, Eleonora\";i:3;s:18:\"DI SANTE, Stefania\";i:4;s:16:\"RICEVUTO, Enrico\";i:5;s:14:\"DOLO, Vincenza\";i:6;s:19:\"TOMBOLINI, Vincenzo\";i:7;s:20:\"JANNINI, Emmanuele A\";i:8;s:18:\"FESTUCCIA, Claudio\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:113:\"Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models\";s:8:\"\u0000*\u0000place\";s:6:\"Athens\";s:6:\"\u0000*\u0000pub\";s:58:\"Editorial Academy of the International Journal of Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models\";s:9:\"\u0000*\u0000jtitle\";s:33:\"International journal of oncology\";s:9:\"\u0000*\u0000stitle\";s:13:\"Int. j. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"711\";s:8:\"\u0000*\u0000epage\";s:3:\"720\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1019-6439\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"LUCA GRAVINA\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Giovanni\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:19:\"MARAMPON, Francesco\";i:1;s:14:\"GIUSTI, Ilaria\";i:2;s:16:\"CAROSA, Eleonora\";i:3;s:18:\"DI SANTE, Stefania\";i:4;s:16:\"RICEVUTO, Enrico\";i:5;s:14:\"DOLO, Vincenza\";i:6;s:19:\"TOMBOLINI, Vincenzo\";i:7;s:20:\"JANNINI, Emmanuele A\";i:8;s:18:\"FESTUCCIA, Claudio\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:113:\"Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models\";s:8:\"\u0000*\u0000place\";s:6:\"Athens\";s:6:\"\u0000*\u0000pub\";s:58:\"Editorial Academy of the International Journal of Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models\";s:9:\"\u0000*\u0000jtitle\";s:33:\"International journal of oncology\";s:9:\"\u0000*\u0000stitle\";s:13:\"Int. j. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"711\";s:8:\"\u0000*\u0000epage\";s:3:\"720\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1019-6439\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"LUCA GRAVINA\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Giovanni\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:19:\"MARAMPON, Francesco\";i:1;s:14:\"GIUSTI, Ilaria\";i:2;s:16:\"CAROSA, Eleonora\";i:3;s:18:\"DI SANTE, Stefania\";i:4;s:16:\"RICEVUTO, Enrico\";i:5;s:14:\"DOLO, Vincenza\";i:6;s:19:\"TOMBOLINI, Vincenzo\";i:7;s:20:\"JANNINI, Emmanuele A\";i:8;s:18:\"FESTUCCIA, Claudio\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:113:\"Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models\";s:8:\"\u0000*\u0000place\";s:6:\"Athens\";s:6:\"\u0000*\u0000pub\";s:58:\"Editorial Academy of the International Journal of Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models\";s:9:\"\u0000*\u0000jtitle\";s:33:\"International journal of oncology\";s:9:\"\u0000*\u0000stitle\";s:13:\"Int. j. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"711\";s:8:\"\u0000*\u0000epage\";s:3:\"720\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1019-6439\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"LUCA GRAVINA\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Giovanni\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:19:\"MARAMPON, Francesco\";i:1;s:14:\"GIUSTI, Ilaria\";i:2;s:16:\"CAROSA, Eleonora\";i:3;s:18:\"DI SANTE, Stefania\";i:4;s:16:\"RICEVUTO, Enrico\";i:5;s:14:\"DOLO, Vincenza\";i:6;s:19:\"TOMBOLINI, Vincenzo\";i:7;s:20:\"JANNINI, Emmanuele A\";i:8;s:18:\"FESTUCCIA, Claudio\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:113:\"Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models\";s:8:\"\u0000*\u0000place\";s:6:\"Athens\";s:6:\"\u0000*\u0000pub\";s:58:\"Editorial Academy of the International Journal of Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models\";s:9:\"\u0000*\u0000jtitle\";s:33:\"International journal of oncology\";s:9:\"\u0000*\u0000stitle\";s:13:\"Int. j. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"711\";s:8:\"\u0000*\u0000epage\";s:3:\"720\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1019-6439\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"LUCA GRAVINA\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Giovanni\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:19:\"MARAMPON, Francesco\";i:1;s:14:\"GIUSTI, Ilaria\";i:2;s:16:\"CAROSA, Eleonora\";i:3;s:18:\"DI SANTE, Stefania\";i:4;s:16:\"RICEVUTO, Enrico\";i:5;s:14:\"DOLO, Vincenza\";i:6;s:19:\"TOMBOLINI, Vincenzo\";i:7;s:20:\"JANNINI, Emmanuele A\";i:8;s:18:\"FESTUCCIA, Claudio\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:113:\"Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models\";s:8:\"\u0000*\u0000place\";s:6:\"Athens\";s:6:\"\u0000*\u0000pub\";s:58:\"Editorial Academy of the International Journal of Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
